PVR and neoplasm: A small molecule, rediocide A (28), isolated from Trigonostemon rediocides, was shown to reduce the expression of CD155 in A549 and H1299 cells by 11% and 14%, respectively, thus blocking the tumor immune resistance to NK cells [74].